Suzhou Ruixun Biotechnology

Developer of PCR instruments for single molecule quantification

placeSuzhou, Jiangsu, China calendar_todayFounded 2017 language rainsurebio.com

Innovation

9 patent families (3 granted) — focus: Chemistry & metallurgy, Operations & transport, Emerging technologies; filing pace slowing. Cited 61 times.

YearFilings
20185
20192
20232

Social engagement

Social engagement: 1.7K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Volcanics Venture, Main Road Investment Fund Management, Yuanbio Venture Capital, Future Capital.

Investor typeCountShare
Venture capital571%
Private equity114%
Other / undisclosed114%

Recent activity

2 Jul 2026
Milestone
cert
4 Jun 2026
Event
2nd Annual Unite for Sepsis Symposium
Coming soon